STENTYS (Paris:STNT) (FR0010949404 — STNT), a medical technology company commercializing, in Europe, the world’s first and only Self-Apposing® stent to treat acute myocardial infarction (AMI), today announces revenues for the third-quarter and nine-months ended September 30, 2014.
Help employers find you! Check out all the jobs and post your resume.
